Se-Natal 19
NDC 13925-116, .beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, calcium pantothenate, calcium carbonate, ferrous fumarate, zinc oxide and docusate sodium, tablet, from Seton Pharmaceuticals.
- Product NDC
- 13925-116
- Status
- Listed
- Labeler
- Seton Pharmaceuticals
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/13925-116 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- .BETA.-CAROTENE1000 [iU]/1
- ASCORBIC ACID100 mg/1
- CHOLECALCIFEROL400 [iU]/1
- .ALPHA.-TOCOPHEROL ACETATE, DL-30 mg/1
- THIAMINE3 mg/1
- RIBOFLAVIN3 mg/1
- NIACINAMIDE15 mg/1
- PYRIDOXINE HYDROCHLORIDE20 mg/1
- FOLIC ACID1 mg/1
- CYANOCOBALAMIN12 ug/1
- CALCIUM PANTOTHENATE7 mg/1
- CALCIUM CARBONATE200 mg/1
- FERROUS FUMARATE29 mg/1
- ZINC OXIDE20 mg/1
- DOCUSATE SODIUM25 mg/1
Pharmacologic classes
Analogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]; Cations, Divalent [CS]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]; Increased Coagulation Factor Activity [PE]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Vitamin B 12 [CS]; Vitamin B 6 [Chemical/Ingredient]; Vitamin B12 [EPC]; Vitamin B6 Analog [EPC]; Vitamin C [EPC]; Vitamin D [CS]; Vitamin D [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 13925-116-01 | 13925011601 | 100 TABLET in 1 BOTTLE (13925-116-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/635104e6-6a53-4684-ac9a-7ac31b33083d
Use it
Look up 13925-116 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/13925-116 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 13925-116. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.